Duloxetine
Product Images NDC 43063-877

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 43063-877). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image (43063877)

Image (43063877)
This is a medication package for a drug called Duloxetine. It contains 90 capsules, each with 30mg of Duloxetine. The medication is made by a company called Blue Pharmaceuticals, located in Oklahoma City. The package has a warning to keep the medication out of reach of children, and instructions for dosage and storage can be found in the package insert. The medication is delayed-release and each capsule contains 33mg of Duloxetine HCl USP. There is also information about potential side effects and a number to call to report them to the FDA.*
FDA Label Image

Figure 1: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (mdd Study 5) (Duloxetine Fig1)

Figure 1: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Relapse (mdd Study 5) (Duloxetine Fig1)
FDA Label Image

Fig2 (Duloxetine Fig2)

Fig2 (Duloxetine Fig2)
FDA Label Image

Figure 3: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (DPNP-1)

Figure 3: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (DPNP-1)
FDA Label Image

Figure 4: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (DPNP-2)

Figure 4: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity (DPNP-2)
FDA Label Image

Figure 7: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Clbp-1 (Duloxetine Fig5)

Figure 7: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Clbp-1 (Duloxetine Fig5)
The text depicts a graph showing the percentage of patients whose pain improved from baseline, with different levels of improvement indicated on the Y-axis ranging from 10% to 80%. The X-axis shows the percent improvement in pain, with increments of 10%, ranging from zero to 100%. The graph compares the effects of duloxetine administered twice daily versus once daily, as well as a placebo control group. The percentage of patients who experienced improvement was highest with duloxetine 60mg twice daily, followed by once daily, with the placebo group having the lowest percentage of patients who experienced improvement.*
FDA Label Image

Figure 8: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Clbp-3 (Duloxetine Fig6)

Figure 8: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Clbp-3 (Duloxetine Fig6)
This is a chart showing improvement in pain from baseline for patients taking different doses of Duloxetine and placebo. The x-axis shows the percentage of improvement in pain, and the y-axis shows the various doses of Duloxetine and placebo. The chart appears to be part of a research study evaluating the effectiveness of Duloxetine in treating pain.*
FDA Label Image

Figure 9: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Oa-1 (Duloxetine Fig7)

Figure 9: Percentage Of Patients Achieving Various Levels Of Pain Relief As Measured By 24-hour Average Pain Severity – Oa-1 (Duloxetine Fig7)
The given text represents a graph or chart showing the percentage of patients improved in the placebo group and the Duloxetine 60/120 mg once group. The X-axis of the graph ranges from 0 to 100, while the Y-axis denotes the percentage of patients in the groups. The graph also shows the percentage improvement in pain from baseline (BOCF). Therefore, this text provides a statistical representation of the effectiveness of Duloxetine in comparison to the Placebo.*
FDA Label Image

Duloxetine Fig8

Duloxetine Fig8
FDA Label Image

Duloxetine Fig9

Duloxetine Fig9
This text appears to be a chart or graph showing the percentage of pain improvement for patients taking a medication called Placeto and Duloxetine at doses of 60/120 mg once daily. The percent improvement in pain is plotted against a baseline value. There is not enough information given to determine the scale or meaning of the X-axis values.*
FDA Label Image

Structure (Duloxetine Str)

Structure (Duloxetine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.